Positron emission tomography in multiple sclerosis - straight to the target

被引:50
作者
Bodini, Benedetta [1 ,2 ]
Tonietto, Matteo [1 ,3 ]
Airas, Laura [4 ,5 ]
Stankoff, Bruno [1 ,2 ]
机构
[1] Sorbonne Univ, Paris Brain Inst, CNRS, INSERM,ICM, Paris, France
[2] St Antoine Hosp, AP HP, Dept Neurol, Paris, France
[3] Univ Paris Saclay, Serv Hosp Freder Joliot, INSERM, CEA,CNRS,BioMaps, Orsay, France
[4] Turku Univ Hosp, Div Clin Neurosci, Turku PET Ctr, Turku, Finland
[5] Univ Turku, Turku, Finland
关键词
18-KDA TRANSLOCATOR PROTEIN; REFERENCE REGION EXTRACTION; MONOAMINE-OXIDASE-B; WHITE-MATTER; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS; MOUSE MODEL; PET; BRAIN; BINDING;
D O I
10.1038/s41582-021-00537-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Following the impressive progress in the treatment of relapsing-remitting multiple sclerosis (MS), the major challenge ahead is the development of treatments to prevent or delay the irreversible accumulation of clinical disability in progressive forms of the disease. The substrate of clinical progression is neuro-axonal degeneration, and a deep understanding of the mechanisms that underlie this process is a precondition for the development of therapies for progressive MS. PET imaging involves the use of radiolabelled compounds that bind to specific cellular and metabolic targets, thereby enabling direct in vivo measurement of several pathological processes. This approach can provide key insights into the clinical relevance of these processes and their chronological sequence during the disease course. In this Review, we focus on the contribution that PET is making to our understanding of extraneuronal and intraneuronal mechanisms that are involved in the pathogenesis of irreversible neuro-axonal damage in MS. We consider the major challenges with the use of PET in MS and the steps necessary to realize clinical benefits of the technique. In addition, we discuss the potential of emerging PET tracers and future applications of existing compounds to facilitate the identification of effective neuroprotective treatments for patients with MS. In this Review, Bodini et al. discuss the contribution that PET is making to our understanding of mechanisms involved in the pathogenesis of irreversible neuro-axonal damage that underlies progression in multiple sclerosis.
引用
收藏
页码:663 / 675
页数:13
相关论文
共 50 条
[41]   Quantification of Tumor Vascular Permeability and Blood Volume by Positron Emission Tomography [J].
Chen, Haojun ;
Tong, Xiao ;
Lang, Lixin ;
Jacobson, Orit ;
Yung, Bryant C. ;
Yang, Xiangyu ;
Bai, Ruiliang ;
Kiesewetter, Dale O. ;
Ma, Ying ;
Wu, Hua ;
Niu, Gang ;
Chen, Xiaoyuan .
THERANOSTICS, 2017, 7 (09) :2363-2376
[42]   Automated quantification of amyloid positron emission tomography: a comparison of PMOD and MIMneuro [J].
Choi, Woo Hee ;
Um, Yoo Hyun ;
Jung, Won Sang ;
Kim, Sung Hoon .
ANNALS OF NUCLEAR MEDICINE, 2016, 30 (10) :682-689
[43]   Potential application of neogalactosylalbumin in positron emission tomography evaluation of liver function [J].
Du, Shun-Da ;
Li, Shao-Hua ;
Jin, Bao ;
Zhu, Zhao-Hui ;
Dang, Yong-Hong ;
Xing, Hai-Qun ;
Li, Fang ;
Wang, Xue-Bing ;
Lu, Xin ;
Sang, Xin-Ting ;
Yang, Hua-Yu ;
Zhong, Shou-Xian ;
Mao, Yi-Lei .
WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (23) :4278-4284
[44]   Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain [J].
Friden, Markus ;
Wennerberg, Marie ;
Antonsson, Madeleine ;
Sandberg-Stall, Maria ;
Farde, Lars ;
Schou, Magnus .
EJNMMI RESEARCH, 2014, 4 :1-8
[45]   Positron emission tomography in schizophrenia [J].
Lopez-Ibor, JJ ;
López-Ibor, MI ;
Montz, R .
CONTEMPORARY NEUROPSYCHIATRY, 2001, :272-278
[46]   Positron emission tomography in cardiology [J].
Rouzet, F. ;
Hyafil, F. ;
Leygnac, S. ;
Ben Azzouna, R. ;
Sorbets, E. ;
Burg, S. ;
Le Guludec, D. .
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (08) :438-444
[47]   Positron emission tomography: PET [J].
Sugano, Y .
JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, 1996, 54 (05) :401-409
[48]   Positron emission tomography in dementia [J].
Santens, P ;
Petit, H .
ACTA NEUROLOGICA BELGICA, 1997, 97 (03) :192-195
[49]   Positron Emission Tomography/Computed Tomography in Melanoma [J].
Bourgeois, Austin C. ;
Chang, Ted T. ;
Fish, Lindsay M. ;
Bradley, Yong C. .
RADIOLOGIC CLINICS OF NORTH AMERICA, 2013, 51 (05) :865-+
[50]   Positron emission tomography imaging of lung cancer: An overview of alternative positron emission tomography tracers beyond F18 fluorodeoxyglucose [J].
Zhu, Jing ;
Pan, Fei ;
Cai, Huawei ;
Pan, Lili ;
Li, Yalun ;
Li, Lin ;
Li, YunChun ;
Wu, Xiaoai ;
Fan, Hong .
FRONTIERS IN MEDICINE, 2022, 9